Efficacy of Crizotinib Combined with Chemotherapy in Treating Advanced Non-Small-Cell Lung Cancer and Effect on Patients' Quality of Life and Adverse Reaction Rate

PURPOSE: To explore the efficacy of crizotinib combined with chemotherapy in treating advanced non-small-cell lung cancer (NSCLC) and its effect on patients' quality of life (QOL) and adverse reaction rate (ARR). METHODS: 90 advanced NSCLC patients admitted to our hospital (from 01, 2019 to 01,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zaiqi, Wang, Yun, Sun, Yonghua, Lin, Gaoyang, Zhao, Zhenqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930210/
https://www.ncbi.nlm.nih.gov/pubmed/35310186
http://dx.doi.org/10.1155/2022/7898737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930210/
https://www.ncbi.nlm.nih.gov/pubmed/35310186
http://dx.doi.org/10.1155/2022/7898737

Ejemplares similares